Home > Boards > US Listed > Medical - Healthcare > Acasti Pharma, Inc (ACST)

$ACST The halt is unusual for an offering.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
I.B.Broke Member Profile
 
Followed By 10
Posts 518
Boards Moderated 0
Alias Born 09/04/14
160x600 placeholder
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 7/15/2019 5:16:42 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/5/2019 9:01:41 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 6/26/2019 8:14:02 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/26/2019 8:07:51 AM
Acasti Pharma Provides Fiscal 2019 Year-End Business Update GlobeNewswire Inc. - 6/26/2019 8:05:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/24/2019 9:02:46 AM
Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid Composition GlobeNewswire Inc. - 6/24/2019 9:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/19/2019 8:01:44 AM
Acasti Pharma Schedules Fourth Quarter and Fiscal 2019 Conference Call GlobeNewswire Inc. - 6/19/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/4/2019 9:16:44 AM
Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertrigl... GlobeNewswire Inc. - 6/4/2019 9:15:00 AM
Acasti Issues Shares in Settlement of Claims with Former Chief Executive Officer GlobeNewswire Inc. - 5/23/2019 5:00:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/21/2019 7:32:31 AM
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference GlobeNewswire Inc. - 5/21/2019 7:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/15/2019 7:57:19 AM
Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel GlobeNewswire Inc. - 5/15/2019 7:55:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/10/2019 10:06:44 AM
Acasti Settles Claims with Former Chief Executive Officer GlobeNewswire Inc. - 5/10/2019 7:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/24/2019 8:36:27 AM
Acasti Pharma CEO to Present at the ThinkEquity Conference on May 2nd in New York City GlobeNewswire Inc. - 4/24/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/15/2019 9:16:25 AM
Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia... GlobeNewswire Inc. - 4/15/2019 9:15:00 AM
Acasti Pharma Announces Publication of CaPre Bioavailability Study in Leading Peer-Reviewed Journal GlobeNewswire Inc. - 4/1/2019 9:20:53 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/26/2019 8:31:38 AM
Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd GlobeNewswire Inc. - 3/26/2019 8:30:00 AM
I.B.Broke   Tuesday, 04/24/18 05:32:44 AM
Re: tabuhasna post# 422
Post # of 469 
$ACST The halt is unusual for an offering. The share numbers don't increase, the company is just selling ones they already own to raise more capital. I'm expecting pre-market news.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist